Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|June 3, 2020
Choline PET/CT in Multiple MyelomaCharles Mesguich, Cyrille Hulin, Axelle Lascaux, et al.
Frontiers in Nuclear Medicine|October 2, 2024
<sup></sup> F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative ReviewCharles Mesguich, Cyrille Hulin, Valérie Latrabe, et al.
Annals of Hematology|September 20, 2020
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myelomaCharles Mesguich, Cyrille Hulin, Valerie Latrabe, et al.
Cancers|April 30, 2021
Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell TransplantCharles Mesguich, Valérie Latrabe, Cyrille Hulin, et al.
British Journal of Haematology|August 9, 2019
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practiceFrançoise Huguet, Jean-Michel Cayuela, Nathalie Cambier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2013
Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasmsJulie Dubois, Gabriel Etienne, Audrey Laroche-Clary, et al.
American Journal of Hematology|October 9, 2014
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?Gabriel Etienne, Stéphanie Dulucq, Axelle Lascaux, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITDGaëlle Labouré, Stéphanie Dulucq, Myriam Labopin, et al.
Haematologica|March 12, 2011
Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemiaCaroline Kannengiesser, Mayka Sanchez, Marion Sweeney, et al.
Cancer Medicine|July 28, 2019
Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitorsGabriel Etienne, Stéphanie Dulucq, Françoise Huguet, et al.
Pageof 2